Enhanced Splicing of the First Intron from the Gonadotropin-Releasing Hormone (GnRH) Primary Transcript Is a Prerequisite for Mature GnRH Messenger RNA: Presence of GnRH Neuron-Specific Splicing Factors
Jae Young Seong,
Sungjin Park and
Kyungjin Kim
Department of Molecular Biology and Research Center for Cell
Differentiation Seoul National University Seoul 151742,
Korea
 |
ABSTRACT
|
---|
The rat GnRH gene consists of four short exons
(denoted 1, 2, 3, and 4) and three introns (A, B, and C). All three
introns are spliced from the primary transcript, resulting in a mature
mRNA. Northern blot and RT-PCR analyses showed that the GnRH primary
transcript and its splicing intermediates are more prevalent than the
mature GnRH mRNA in a variety of non-GnRH-producing tissues. To
delineate the possible splicing mechanism of introns, an in
vitro HeLa splicing system was used. Introns B and C were
efficiently spliced, while intron A spanning between exon 1 and exon 2
was not. The retention of intron A was relieved when the 5'- and/or
3'-splice sites of intron A were point mutated based on the consensus
sequence. The splicing activity was even more strengthened when a
putative branchpoint site was moved to the upstream region of the
pyrimidine tract of intron A. Intron A could be partially spliced when
whole exons (2, 3, and 4) were linked up with intron A. There are two
putative exonic splicing enhancers (ESEs) in exon 3 and exon 4. The ESE
on exon 4 (ESE4) is much stronger than that on exon 3. The closer the
ESE4 to the 3'-splice site of intron A, the better the splicing
activity became. However, in the presence of the nuclear extract from
GnRH neurons, there was an enhancement in the splicing activity
notwithstanding the distance between ESE4 and 3'-splice site of intron
A. These results suggest that the ESE4 functions as both the
constitutive and regulated enhancer. Collectively, our study provides
evidence that enhanced splicing of intron A by putative GnRH
neuron-specific splicing factor(s) interacting with the ESEs is a
prerequisite for mature GnRH synthesis.
 |
INTRODUCTION
|
---|
GnRH is a key hypothalamic neuropeptide controlling mammalian
reproduction and sexual development. The rat GnRH gene consists of four
short exons and three large introns (1, 2). In the preoptic area (POA)
of the rat, all three GnRH introns are spliced from the primary gene
transcript (
4,300 bases), resulting in a mature mRNA of about 560
bases. However, despite a low level expression, the mature GnRH mRNA
has been detected in numerous extrahypothalamic tissues such as the
pituitary, ovary, lymphocytes, and certain brain regions (3, 4, 5, 6). GnRH
RNA species retaining the intron A are expressed in human and
monkey reproductive tissues (7, 8), and the GnRH primary transcript
appears to be more prevalent than the mature mRNA in the rat ovary (9).
Recently, Zhen et al. (10) demonstrated that there are
alternative GnRH splicing variants in the mouse olfactory,
hypothalamus, and immortalized GnRH cell lines (Gn11 and NLT).
Roberts and colleagues (11, 12, 13) found a relatively high prevalence of
the GnRH primary transcript and its splicing intermediates in the rat
and mouse POA (1020% of the total gene transcript). In addition, the
rat basal olfactory area, which contains a small amount of GnRH
neurons, showed about 40% of molar ratio of the primary transcript
vs. cytoplasmic mRNA and had a similar amount of the primary
transcript compared with that of the POA (11). In contrast to the
tissues, in immortalized GnRH-producing cells (GT1), the primary
transcript and its splicing intermediates make up less than 2% of the
total GnRH gene transcripts (12). The discrepancy of why the tissues
contain unusually high portions of splicing intermediates is not yet
clearly understood. In the present study, we found that although a
variety of neural and peripheral tissues expressed much smaller amounts
of the mature mRNA than in the POA, they expressed similar amounts of
the GnRH primary transcript and its splicing intermediates. Together
with the previous results, this result suggests the possibility that
splicing intermediates may be arrested in the splicing process in
non-GnRH-producing tissues and that some unspliced GnRH
transcripts in the POA may originate from non-GnRH-producing cells.
Since accurate and efficient splicing is obviously critical for
maintaining the normal function of GnRH-producing cells, in the present
study, we examined the splicing arrest of the GnRH primary transcript
in non-GnRH-producing tissues and whether this arrest could be relieved
by the GT1 nuclear extract (NE).
 |
RESULTS
|
---|
Presence of GnRH Splicing Intermediates in a Variety of Tissues
Using an antisense GnRH riboprobe, Northern blot analysis for the
GnRH transcript in a variety of tissues was performed. Short-term
exposure (3 days) of the hybridized membrane showed an exclusive
expression of the mature GnRH mRNA in the POA, which is known to
contain GnRH-producing cells (14) (Fig. 1A
). Long-term exposure (2 weeks)
revealed additional signals of the mature GnRH mRNA in the olfactory
bulb (OB) and piriform cortex (PC) (Fig. 1B
). Interestingly, several
putative GnRH splicing intermediates longer than mature mRNA were seen
in most tissues examined. To further define the putative GnRH splicing
intermediates in these tissues, RT-PCR analyses with several sets of
primers were performed. To exclude the possible DNA contamination, we
used deoxyribonuclease (DNase)-treated RNA samples, and PCR reaction
without RT showed no DNA or other contamination in all tissues examined
(data not shown). When the RT-PCR was performed with e1-up primer
located at the 5'-end of the first exon and e3-down primer near the
3'-end of the third exon, the mature GnRH mRNA signals were strongly
observed in the POA, OB, and PC, which is consistent with the Northern
data. In other tissues, the faint mature GnRH mRNA signals were also
detected. In addition, a longer putative GnRH splicing intermediate was
detected in several tissues. To identify this putative GnRH splicing
intermediate, PCR products were applied to Southern hybridization with
the GnRH cDNA, intron A, or intron B probes, respectively. The GnRH
cDNA probe hybridized with both the mature mRNA and the longer PCR
product while intron A probe hybridized only with the longer one. No
hybridization signals were observed in any tissues when intron B probe
was used (Fig. 2A
). These results,
confirmed by DNA sequencing analysis, indicate that the splicing
intermediate contains intron A but not intron B, hence the 1A23
fragment. When the RT-PCR was carried out with the iB-up primer located
in intron B and e4-down primer located in exon 4, two types of splicing
intermediates were observed (Fig. 2B
). These PCR products were
subjected to Southern blot hybridization with GnRH cDNA, intron B, or
intron C probes, showing that the long intermediate contains introns B
and C, and the shorter one contains intron B but not intron C.

View larger version (52K):
[in this window]
[in a new window]
|
Figure 1. Northern Blot Analysis of GnRH Transcripts in a
Variety of Tissues
Total RNAs were extracted by acid guanidinium-phenol-chloroform method.
Thirty micrograms of total RNA were loaded, electrophoresed in a 1.2%
formaldehyde gel, and transferred to a Nytran membrane. The
hybridization was performed using 32P-labeled GnRH
complementary RNA. Membrane was exposed to x-ray films for 3 days
(panel A) and 2 weeks (panel B). 18S RNA hybridization is seen in panel
C. The arrows and arrowheads indicate mature GnRH mRNA
and putative splicing intermediates, respectively.
|
|

View larger version (45K):
[in this window]
[in a new window]
|
Figure 2. RT-PCR and Southern Blot Analyses
Total RNAs from various tissues as shown in Fig. 1 was applied to
RT-PCR analyses with several primer sets (panel A, e1-up and e3-down;
panel B, iB-up and e4-down; panel C, iA-up and e3-down). To verify the
putative GnRH splicing intermediates, these PCR products were subjected
to Southern blot hybridization with the GnRH cDNA, intron A, intron B,
or intron C. The numbers 111 are the same as shown in Fig. 1 .
Arrows to the right side of panel indicate expected PCR
products whose structure and size are shown in diagrams.
Unknown bands in panel B seem to be PCR artifacts.
|
|
One interesting finding is that the splicing intermediate containing
intron A was prevalent in all tissues except the POA as shown in Fig. 2A
. Low level expression of this splicing intermediate in the POA may
be due to PCR competition. Because in the POA the mature mRNA is much
more abundant than other splicing intermediates, only the mature mRNA
may be strongly amplified. This is supported by data in Fig. 2C
showing
similar expression levels of the splicing intermediate (A23 fragment)
among the tissues when iA-up and e3-down primers were used.
Furthermore, from the difference in the ratio of the mature mRNA to the
splicing intermediates among the POA and other tissues, it can be
speculated that the splicing process of premature GnRH splicing
intermediates may be arrested or minimally active in non-GnRH-producing
tissues.
Intrinsic Splicing Weakness of GnRH Intron A
To examine the splicing activity of each GnRH intron, splicing
substrates containing each intron and its neighboring exons were
constructed. Unnecessary inner regions of the introns were partially
truncated (these were denoted 1
A2, 2
B3, and 3
C4,
respectively), due to the sizes of native introns being too long to be
easily transcribed in vitro. Since the HeLa nuclear extract
(NE) contains the general splicing machinery, the HeLa NE has been used
to investigate the splicing mechanism of RNAs derived even from
different species such as fly, chicken, and mouse (15, 16, 17). HeLa NE can
also serve as a control NE compared with other NE containing specific
splicing factors (17). Application of 2
B3 and 3
C4 RNA transcripts
produced spliced exons (Fig. 3
) and their
splicing lariats, indicating that introns B and C could be efficiently
spliced by the HeLa NE. However, 1
A2 could not be or was marginally
spliced in this system (Fig. 3
). This result suggests the weakness of
the GnRH intron A splice sites. Note that spliced RNAs and their
splicing lariats were identified by RNA size markers and running on
higher percentage gels. Spliced RNAs were also confirmed by RT-PCR.
There were several unexpected bands that appear to be cryptic splicing
intermediates (see Fig. 3
and following figures).

View larger version (33K):
[in this window]
[in a new window]
|
Figure 3. In Vitro Splicing Activity of GnRH
Introns
The 32P-labeled RNA substrates consisting of each GnRH
intron and its neighboring exons were synthesized by in
vitro transcription. The RNAs purified from the 6%
polyacrylamide gels containing 8 M urea were incubated with
HeLa NE as described in Materials and Methods. The
products were electrophoresed on the 6% polyacrylamide gels containing
8 M urea and then subjected to autoradiography. RNA
substrates are shown at the top of the gels, and the
time of incubation is specified at the top of each lane.
Illustrated RNA structures in the right sides of gels
were identified by RNA size markers and running on higher percentage
gels. Spliced RNA (exon-exon) was confirmed by RT-PCR using
gel-purified RNAs. Other bands in this and following figures are
cryptic splicing intermediate(s). The schematic diagram on the
bottom panel shows the restriction map of the GnRH gene and RNA
substrates. The size of substrates containing each intron and their
spliced products are shown in parentheses.
|
|
A critical step in the splicing process appears to be the initial
recognition of the correct pairs of the 5'- and 3'-splice sites by the
splicing apparatus (18, 19). The 5'-consensus sequence is GURAGU,
whereas the 3'-consensus contains a polypyrimidine tract followed by
CAG (YnNCAG). The branchpoint sequence (BPS) located in the upstream
region of the pyrimidine tract is also regarded as a part of the
3'-consensus (YNRAY) (20, 21). Based on the sequence analyses of the
5'- and 3'-splice site of intron A, we speculated that the 5'- and/or
3'-splice sites of intron A are very weak compared with those of intron
B and C. To examine which splice site is the limiting factor in the
splicing activity of intron A, the 5'- and 3'-splice sites were point
mutated toward consensus sequence. Two mismatches of the 5'-splice site
(GUAAAA) were replaced by GUAAGU. Three of G bases on the pyrimidine
tract were changed to C and one U on anchoring site was changed to C in
the 3'-splice site mutation. Furthermore, in the BPS mutation, a
possible BPS of intron A was moved to the upstream region of the
pyrimidine tract. While the mutation of 5'-splice site resulted in a
slight effect, the mutation of 3' and/or 5' produced more significant
effects. When the BPS was moved to the upstream region of pyrimidine
tract, the most efficient splicing effect was observed (Fig. 4
). These results imply that the low
splicing activity of intron A may be due to the intrinsic weakness of
the 3'-splice site of intron A, resulting in an arrest of splicing
intermediates such as 1A234 seen in Fig. 2A
. However, it cannot be
concluded that splicing of intron A is nonexistent in
non-GnRH-producing tissues, since Fig. 2A
showed that low-level
expression of the mature GnRH mRNA was observed even in
non-GnRH-producing tissues. Therefore, PCR data shown in Fig. 2A
are in
part inconsistent with the in vitro splicing result in which
no splicing of intron A was seen. A recent report demonstrated that
suboptimal 5'- and 3'-splice sites cause retention of an intron in
bovine GH pre-mRNA and that the efficient splicing of this intron is
ensured by the presence of a purine-rich exonic splicing enhancer (22, 23). This postulates that enhancer-like activity of other exons (exons
3 and 4) may enhance splicing of intron A when these exons are
connected to exon 2.

View larger version (38K):
[in this window]
[in a new window]
|
Figure 4. Site-Directed Mutation of the 5'- and 3'-Splice
Sites of Intron A
The schematic diagram shows the consensus sequence of
the 5'- and 3'-splice site and mutated RNA substrates. Two bases
(GUAAAA) of the 5'-splice site were changed to
GUAAGU. In the 3'-splice site mutation, three G
were changed to C, and one U is replaced by C as indicated by
bold and underlined characters. In the BPS mutation, the
putative BPS within the pyrimidine tract is disrupted and moved to
upstream region of the pyrimidine tract. Splicing reaction was
performed for 3 h in HeLa NE. RNA size markers are shown to the
left of the gel, and structures of the RNAs are illustrated
on the right.
|
|
Activation of Intron A Splicing by the Exonic Splicing Enhancers in
Exon 3 and Exon 4
The sequence analysis of the GnRH exons revealed that there are
two purine-rich sequences on exon 3 (ATGGGCAAGGAGGAGGA) and exon 4
(GAAGAGGAA-GCUGGGCAGAAGAAGA) that are homologous to the exonic splicing
enhancer (ESE) (24). To examine the possible enhancer-like activities
of exon 3 and exon 4, the cDNA of p1
A234 was digested by several
restriction enzymes (HincII, SfuI,
SacI, or BamHI) (Fig. 5
), and their RNA
transcripts were applied to the splicing reaction. Although little of
1
AH was spliced, others (1
ASf, 1
ASc, and 1
ABam) that
contain exon 3 and/or exon 4 showed a slightly increased splicing (Fig. 6
). To further
delineate the possible role of ESEs in exon 3 (ESE3) and exon 4 (ESE4)
in the splicing activity, we connected each ESE to the 3'-splice site
of intron A. Placing the ESE3 close to the 3'-splice site (1
A(CC)Sf)
showed a very slight splicing effect. The weaker splicing of
1
A(CC)Sf compared with 1
ASf or 1
ASc was unexpected. However,
it is possible that when exon 3 joins to exon 2, the ESE3 directly
links to the five purine bases (AAGAG) at the 3'-end of exon 2 and
strengthens the ESE3. 1
A(CSc)Bam containing only the ESE4 showed
increased activities (Fig. 7A
). In
1
A(CSc)Bam, although the distance between ESE4 and intron A is
longer than that in 1
A(CC)Bam, similar splicing activity was
detected, which may be due to the strong activity of the ESE4 and/or an
additive effect of the ESE3 and ESE4. To examine the role of ESE4 in
the absence of ESE3, p1
A234 was digested with HincII in
exon 2 and SfuI or SacI site in exon 3. These
gene constructs thus lack ESE3, and the distance between ESE4 and
intron A 3'-splice site of 1
ABam (251 bases) was shortened to 112
bases or 58 bases in 1
A(HSf)Bam and 1
A(HSc)Bam RNA, respectively.
Application of these RNA transcripts showed that shortening the
distance between the 3'-splice site of intron A and the ESE4 led to an
increase in splicing activity and that ESE4 alone was strong enough for
enhancing the intron A splicing (Fig. 7B
). These results indicate that
the ESEs located in exon 3 and exon 4 may participate in the splicing
of intron A, and such a partial splicing of intron A from the 1A234 may
account for the extremely low-level expression of the mature GnRH mRNA
in non-GnRH-producing cells (Fig. 2
). However, this result could not
explain the mechanism by which GnRH neurons efficiently splice intron A
from splicing intermediates.

View larger version (19K):
[in this window]
[in a new window]
|
Figure 6. Effect of the Presumptive ESEs on Intron A Splicing
In the DNA construct, p1 A234, ESEs located in exon 3 and exon 4, and
restriction enzyme sites are shown in the schematic
diagram. To examine the possible enhancer-like activities of
exon 3 and exon 4, the cDNA of p1 A234 was digested by several
restriction enzymes (HincII, SfuI,
SacI, or BamHI), and their in
vitro transcribed RNAs were incubated in HeLa NE for 3 h.
Arrowheads indicate the spliced products.
|
|
Presence of GT1-Specific Splicing Factor(s) Acting on the ESE of
Exon 4
It can be postulated that GnRH neurons possess unique splicing
factors that act on the ESEs to enhance the splicing of intron A. To
examine this possibility, we isolated crude NEs from the hypothalamic
GT1 neuronal cells, which are well known GnRH-producing neurons (25),
and applied this GT1 NE to the splicing reaction. First, the 1
ABam
RNA that contains two ESEs was examined in the absence or presence of
GT1 NE. Because of the difficulty in obtaining a high concentration of
GT1 NE, we were unable to totally replace HeLa NE with GT1 NE at the
same concentration. Rather, we retained the total volume (10 µl) but
replaced HeLa NE (50 µg) with 10 or 20 µg of GT1 NE as shown in
Fig. 8
. Although we did not use a
constant concentration of NE, we found that this replacement
drastically increased splicing activity of 1
ABam in a dose-dependent
manner, but not in 3
C4Bam construct (please compare A and B in Fig. 8
). This result shows that GT1 NE specifically recognizes the 1
ABam
structure rather than 3
C4Bam. When 3
C4Bam RNA in which the ESE4
is close to the 3'-splice site was subjected, GT1 NE did not show an
additive effect on splicing activity of 3
C4Bam RNA, but rather
slightly decreased the splicing activity (Fig. 8B
). Although the reason
for the lack of increase in splicing of 3
C4Bam by GT1 NE is not
clear, GT1 NE would not be required for the splicing process of highly
conserved 3'-splice site such as intron C.

View larger version (22K):
[in this window]
[in a new window]
|
Figure 8. Enhanced Splicing of Intron A in the Presence of
the GT1 NE
To examine the possible participation of some splicing factors from
GnRH-producing cells in GnRH pre-RNA splicing, the GT1 NE was isolated
and added to the splicing reaction. The RNA substrate containing exon 1
and intron A followed by exons 2, 3, and 4 (1 ABam) was used because
this RNA is mostly arrested in nonspecific tissues and consists of the
putative ESEs (A). Right panel shows the effect of GT1
NE on the ESE4 when the ESE4 is near the 3'-splice site of intron A. As
RNA substrate, 3 C4Bam was used in panel B. In this experiment, a
half-volume (5 µl) of HeLa NE (50 µg) was used in the splicing
reaction, and another half was replaced by NE storage buffer, 10 µg,
or 20 µg of the GT1 NE as shown at the top of the
gels. Splicing reaction was performed for 3 h. Structures of the
RNAs are illustrated to the right of the gel.
|
|
To examine the specific action site of the GT1 NE, 1
AH, 1
ASf,
1
ASc, and 1
ABam RNA were employed to the splicing reaction in the
presence of GT1 NE. Adding the GT1 NE increased the splicing activity
of only 1
ABam RNA, but not in other RNAs (Fig. 9
). This result indicates that putative
regulatory splicing factor(s) from the GT1 NE specifically interacts
with the ESE4 even though the ESE4 is located far from the
3'-splice site of intron A. We also examined whether enhanced splicing
activity of 1
ABam RNA is due to ESE4 alone or a combinational effect
of ESE4 and neighboring ESE3. Splicing activities of pre-mRNAs
containing ESE3 and ESE4 (1
ABam, 1
A(CC)Bam) and containing ESE4
alone (1
A(CSc)Bam, 1
A(HSf) Bam, and 1
A(HSc)Bam) in the
presence or absence of GT1 NE were examined. Complementation of GT1 NE
increased the splicing activity of all constructs (Fig. 10
), indicating that ESE4 alone is
enough for interaction with GT1 NE. To further elucidate the role of
ESE3 and ESE4 in intron A splicing, we mutated some purines to
pyrimidines as shown in the diagram in Fig. 11
. Mutation in ESE3 reduced the intron
A splicing, suggesting a possible additive effect of ESE3 with the
combination of ESE4 on intron A splicing. Mutations in ESE4 were much
more effective than ESE3 mutation, and there was no difference in
mutation effect between ESE4 mutations, indicating that ESE4 sequence
is very specific, and thereby changes in some purine bases critically
disrupted ESE4 activity (Fig. 11
).

View larger version (28K):
[in this window]
[in a new window]
|
Figure 9. The GT1 Nuclear Extract (NE) Specifically Acts on
the ESE4
To examine the specific action site of the GT1 NE on the GnRH exons,
the RNA substrates from the p1 A234 digested by several restriction
enzymes (HincII, SfuI,
SacI, or BamHI) were applied to splicing
reactions. In lanes 14, 10 µl of HeLa NE (100 µg) were used and
in lanes 58, 5 µl of HeLa (50 µg) and 5 µl of GT1 NE (20 µg)
were used. Arrowheads indicate the spliced products. RNA
structures are illustrated between the gels.
|
|

View larger version (52K):
[in this window]
[in a new window]
|
Figure 10. GT1 Nuclear Extract (NE) Further Increases Intron
A Splicing in the Presence of ESE4 Regardless of Distance between ESE4
and 3'-Splice Site of Intron A
Splicing activities of pre-mRNAs containing ESE3 and ESE4
(1 ABam, 1 A(CC)Bam) and containing only ESE4 (1 A(CSc)Bam,
1 A(HSf)Bam and 1 A(HSc)Bam) were examined in the presence or
absence of GT1 NE. For the control, 100 µg of HeLa NE were used
(lanes 1, 3, 5, 7, and 9) and, to examine GT1 NE effect, splicing
reactions were carried out in the mixture of 50 µg HeLa and 20 µg
GT1 NE (lanes 2, 4, 6, 8, and 10). Arrowheads indicate
the spliced products.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
Figure 11. Mutations in ESE3 and ESE4 Significantly Reduce
Intron A Splicing
Some purines of ESE3 or ESE4 were changed to pyrimidines as indicated
by the diagram. 1 ABam RNA and mutated RNAs were
incubated in a HeLa (50 µg) and GT1 (20 µg) nuclear extract mixture
for 3 h at 30 C.
|
|
 |
DISCUSSION
|
---|
The present study demonstrated that the GnRH primary transcript
and its splicing intermediates are illegitimately transcribed in a
variety of classically non-GnRH-producing tissues, and that the
extremely low level of the mature GnRH mRNA, as compared with its
premature splicing intermediates, is most likely due to a weakness of
the intron A splice sites. Furthermore, we showed that splicing of
intron A can partially occur with the help of the ESEs on GnRH exons
and that a certain splicing factor derived from GT1 NE acts on the ESE
of exon 4 to enhance the splicing activity of intron A. These results
strongly suggest that the enhanced splicing activity of intron A is a
prerequisite for mature GnRH mRNA production.
The low level transcription of GnRH mRNA as well as its unspliced
transcripts has been demonstrated in several neural and peripheral
tissues by the sensitive RT-PCR method (3, 4, 5, 6, 7, 8, 9). Figures 1
and 2
show
that among splicing intermediates a very small portion appears to
undergo further processing to mature mRNAs in non-POA tissues, which
are detectable by the RT-PCR method. Although the biological role of
such a low-level expression of mature mRNA in non-POA tissues remains
to be investigated, several reports have suggested that they contribute
to produce local GnRH peptides that are involved in autocrine and/or
paracrine regulation in several tissues, such as pituitary, gonads,
spleen, and the olfactory system (3, 4, 5, 6, 9). We cannot rule out the
possibility that some part of intermediates would be released into the
cytoplasm without further processing to mature GnRH mRNA (7, 8).
Although a number of studies on GnRH transcript retaining intron A or
lacking exon 2 have been published, their biological consequence
has been poorly understood (2, 7, 8, 10).
One interesting finding of the present study is that the GnRH primary
transcript and splicing intermediates are more prevalent than the
mature GnRH mRNA in non-GnRH-producing tissues. This result may be
closely related to the unusually high portion of the GnRH primary
transcript and its splicing intermediates in the animal POA when
compared with GT1 cells showing less than 2% of the premature splicing
intermediates (11, 12, 13). One possible explanation for the discrepancy
between GT1 cells and animal tissues is that more than 10% of the
premature splicing intermediates in the POA may originate from
non-GnRH-producing cells in the POA because other tissues also express
premature splicing intermediates. According to the in vitro
splicing finding that intron A, but not intron B and C, is
poorly spliced, a predominant accumulation of 1A234 RNA in
vivo would be predicted. Surprisingly, as revealed by Northern
blot analysis, it is not the case; rather, there are many splicing
intermediates (Fig. 1
). Currently we do not have a clear explanation
for this result. It is difficult to reconcile in vitro data
with an in vivo situation. It is, however, possible that the
arrest of intron A splicing may cause a rapid degradation of this
splicing intermediate. Indeed, several investigators have described
that nuclear posttranscriptional regulation involves changes in the
stability and accumulation of primary or unspliced transcripts
(26, 27, 28). One recent report showed that a large portion of the
unspliced RNA is degraded before processing and transport to the
cytoplasm without changes in transcriptional rate in certain conditions
(29). It appears that the lack of predominant accumulation of 1A234 RNA
is likely due to degradation of these intermediates. However, this
possibility remains to be examined.
Recently, GnRH splicing variants containing intron A have been
found in the human placenta and monkey reproductive tissues (7, 8),
along with alternative GnRH splicing variants with deletion of the exon
2 in the OB and caudal hypothalamus (10). The present study showed a
lesser splicing activity of intron A than those of introns B and C.
Based on the consensus sequence of splice sites (15), the 5'-sequence
of intron A shows two base mismatches, and the 3'-splice site has many
purines within the polypyrimidine tract. More importantly, a putative
BPS exists within the polypyrimidine tract, although usually the BPS
locates the upstream region of the polypyrimidine tract. Recognition of
the polypyrimidine tract by U2 auxiliary factor (U2AF) is essential for
the binding of U2 small nuclear ribonucleoprotein (snRNP) with
the BPS (30). One of the splicing factors, BBP (branchpoint bridging
protein), can also interact specifically with the pre-mRNA BPS (21).
The increased splicing activity of intron A, when BPS was moved to the
upstream region of the pyrimidine tract, may raise the possibility of
steric hindrance among U2 snRNP, U2AF, BBP, and other splicing factors
in the splicing of intron A. However, this possibility should be
further examined. Together with this BPS switch experiment, increased
splicing activity of intron A when intron A was point-mutated to
strengthen the 5'- and 3'-splice site apparently indicates the
intrinsic weakness of the intron A splice sites.
Sequence analysis of GnRH exons 3 and 4 revealed that there are two
purine-rich sequences, one located in the 5'-region of exon 3 and the
other located in the 5'-region of exon 4. The purine-rich sequences are
well known splicing enhancers that exist within exon sequences located
downstream from introns containing a weak 3'-splice site in a variety
of eukaryotic RNAs (15, 31, 32). The enhancers can increase the
splicing activity of a weak intron without the aid of specific splicing
factor(s), depending on its distance from the 3'-splice site: they must
be located within 100 nucleotides of the regulated intron (15). The
ESE3 appears to be very weak because shortening the distance between
the ESE3 and the 3'-splice site of intron A had little effect on
splicing activity. However, the ESE4 is much stronger than the ESE3.
The activity of the ESE4 is highly dependent on the distance: the
closer the ESE to the 3'-splice site, the stronger the splicing
activity became. Usually, enhancer sequences are recognized by general
splicing factors, such as SR proteins and U1 snRNP. The interaction of
general splicing factors with the enhancer is enough to strengthen the
binding of U2AF to the polypyrimidine tract resulting in an efficient
splicing of the weak intron when the enhancer is near the 3'-splice
site (18, 32). More importantly, efficient splicing activity was
observed despite the long distance between ESE4 and the 3'-splice site
of intron A (
250 bases) in the presence of GT1 NE. This finding
suggests that some specific splicing factor(s) in GT1 NE are required
to maintain the ESE activity because of the long distance from the ESE
to intron A. The regulatory protein-dependent splicing activity of the
enhancer sequence was shown in Drosophila doublesex (dsx)
gene whose alternative splicing relies on the specific splicing
factors, Tra and Tra2 (15). Recently, a neuron-specific splicing
enhancer-binding protein has been identified (17) along with
neuron-specific RNA-binding proteins, Hu proteins (33). Interestingly,
Hu proteins showed strong homology with the Drosophila
splicing factor sxl, and expression of Hu gene products revealed
developmental stage specificity and different spatial distribution in
the central nervous system. It was also suggested that different
combinations of Hu proteins in individual neurons determine different
neuron-specific aspects of posttranscriptional RNA regulation (33).
These findings raise the possibility that there is a GnRH
neuron-specific splicing system and associated specific splicing
factors.
It is also notable that the GnRH gene uses the ESE4 to
facilitate the splicing of intron A, since other ESEs are usually
located downstream of the neighboring intron (24, 32). Thus, the ESE4
may not be active in the primary transcript status, but following the
splicing of introns B and C from the primary transcript, ESE4 may act
on the intron A splicing. Therefore, it can be assumed that there is a
specified order in the GnRH transcript splicing system. Enhanced
splicing activity by the interaction of GnRH neuron-specific splicing
factor(s) to the ESE seems to take place in a certain condition
especially when the 3'-splice site is weak. Failure of enhanced
splicing of 3
C4Bam pre-mRNA with GT1 NE indicates that such an
interaction between GnRH neuron-specific splicing and ESE4 appears not
to be required for the splicing of introns that show highly conserved
3'-splice site like intron C. It is postulated that the proper and
temporal association of the specific splicing factor(s) with the ESE4
may be another regulation mechanism to control the efficient splicing
of the primary transcript. It is also possible that GT1-specific
activity may require the presence of both ESE4 and ESE3. In this case,
ESE3 may serve as a bridge for the interaction of ESE4 and a weak
3'-splice site. It remains to be resolved whether GT1-specific splicing
factors directly bind to ESE3 and/or ESE4 or to other proteins that are
already bound to ESEs.
Mass production of the mature GnRH mRNA by an efficient and accurate
splicing process is required for the production of intact GnRH peptide,
which is obviously critical for the normal function of GnRH neurons.
Therefore, it can be assumed that the presence of the GnRH
neuron-specific splicing factor(s) is one of the selection systems to
maintain the specificity of GnRH neurons. Issues such as identification
of the splicing factors involved in the facilitated splicing of intron
A in GnRH-producing cells, and the interaction of splicing factors with
GnRH exonic enhancers and their protein-protein-snRNP interaction
during the splicing of intron A, should be addressed for the
elucidation of splicing mechanisms in the mammalian brain.
 |
MATERIALS AND METHODS
|
---|
Animals and Tissue Preparation
Adult female Sprague Dawley rats (weighing 200 g) were
housed in a temperature-controlled condition under a 14-h light, 10-h
dark photocycle (light on at 0600 h) with food and water supplied
ad libitum. Rats were killed by decapitation between 1400
and 1600 h. Each brain was removed from the skull and chilled on
ice. The POA and other brain regions such as the cortex, OB, PC, brain
stem, and cerebellum were sampled. Of the peripheral tissues, the
pituitary, ovary, testis, kidney, and adrenal gland were removed.
Animal experiments were conducted in accordance with the Guidelines for
the Care and Use of Experimental Animals at Seoul National
University.
Northern Blot Hybridization Assay
Total RNA was extracted with the acid guanidinium
thiocyanate-phenol-chloroform method (34). RNA (30 µg) was dissolved
in distilled water and denatured in 50% formamide, 6.2% formaldehyde,
20 mM MOPS (3-[N-morpholino]propanesulfonic
acid), 5 mM sodium acetate, and 1 mM EDTA at 60
C for 5 min. Electrophoresis was performed at 100 V for 1.5 h in a
submarine 1.2% formaldehyde agarose gel. RNA was transferred to Nytran
filter (pore size: 0.45 µm, Schleicher & Schuell, Inc.,
Dachen, Germany) for 18 h by capillary transfer. The GnRH RNA
probe labeled with 32P-UTP (Amersham Pharmacia Biotech, Little Chalfort, UK) was prepared by in
vitro transcription of the rat GnRH cDNA clone inserted into
plasmid pGEM4, which was generously provided by Dr. Kelly Mayo
(Northwestern University, Evanston, IL). Hybridization procedures and
rehybridization with 18S cDNA were performed as previously described
(35).
Oligonucleotides
e1-up 5'-CACTATGGTCACCAGCGGGG-3' (20 mer) e3-down
5'-AGAGCTCCTCGCAGATCCCTAAGC-3' (24 mer) e4-down
5'-GCTGCTGGGTATAGAAATGCG-3' (21 mer) iA-up
5'-CCCTCTGTGTCTTGATGTCCC-3' (21 mer) iB-up
5'-CATCACTTCTCCACCCCTTG-3' (20 mer)
RT-PCR Analyses
RT-PCR was carried out as previously described (36, 37). RNA
samples (1 µg) were applied to the RT reaction mixture containing 200
U of RNaseH- moloney murine leukemia virus (MMLV) reverse
transcriptase (Life Technologies, Inc., Gaithersburg, MD),
50 pmol of random hexamer, 20 U of RNase inhibitor (Promega Corp., Madison, WI), 10 mM Tris-HCl, pH 8.3, 50
mM KCl, 5 mM MgCl2, and 1
mM deoxynucleoside triphosphate. The RT mixture was
overlaid by 50 µl of light mineral oil. The RT reaction was carried
out at 37 C for 30 min followed by a 5-min denaturation period at 99 C.
Subsequently, 80 µl of the PCR reaction mixture containing 10
mM Tris-HCl, pH 8.3, 50 mM KCl, 2
mM MgCl2, 50 pmol of upstream and downstream
primers, and 2.5 U of Taq DNA polymerase (Perkin Elmer Corp., Norwalk, CT) were added. Forty cycles of PCR
amplification were carried out with the condition of denaturation at 94
C for 1 min, primer annealing at 60 C for 1 min, and primer extension
at 72 C for 2 min. Ten-microliter aliquots of PCR products were
electrophoresed on an 1.5% agarose gel in Tris-acetate-EDTA
buffer, stained with ethidium bromide, and photographed under UV
illumination with Polaroid 667 film (Polaroid, Cambridge, MA).
Southern Blot Hybridization
After rinsing with bidistilled water, the gel was soaked in 0.5
M NaOH, 1 M NaCl solution for denaturation of
double-strand DNA followed by resoaking in 0.5 M Tris-HCl
(pH 7.4), 1.5 M NaCl solution for neutralization. The DNA
was then blotted onto Nytran membrane by capillary transfer method. The
Nytran membrane was prehybridized in 50% formamide, 10 x
Denhardt solution, 6 x SSPE, 1% SDS, 50 µg/ml salmon sperm
DNA. Hybridization was carried out overnight at 42 C in the same buffer
including 32P-labeled probes. The membrane was washed twice
in 6x SSPE, 0.5% SDS at room temperature for 15 min and twice in 1x
SSPE, 1% SDS at 42 C for 15 min. The washed filter was exposed to
x-ray film at -70 C for 1 day (36). The probes used in this study are:
the intron A probe made by cutting HincII and
PstI sites in the intron A; the intron B probe containing
the DNA fragment from iB-up primer to SacI site in intron B;
the intron C probe consisting of the SacI site in the 3'-end
of exon 3 to the NcoI site in intron C; and the GnRH cDNA
probe containing all exons.
DNA Constructions and In Vitro Splicing
Substrates
The GnRH DNA fragment containing exon 1, intron A, exons 2 and 3
(1A23) was obtained by RT-PCR with e1-up and e3-down primers and
subsequently cloned into the pGEM-T vector (Promega Corp.)
(This gene construct was denoted as p1A23.) DNA fragment 1A23Sf
obtained by digestion with SphI and SfuI from
p1A23 was cloned into the p1234 digested with SphI and
SfuI, generating p1A234. Subsequently, StyI and
PstI sites within intron A were digested and ligated,
resulting in p1
A234. This plasmid was linearized by
HincII, SfuI, SacI, or
BamHI and used as a template for in vitro
transcription. In vitro transcribed RNAs from these
templates were denoted as 1
AH, 1
ASf, 1
ASc, and 1
ABam,
respectively (Fig. 5
). To shorten the distance of the ESEs from the
3'-splice site of intron A, we artificially made ClaI sites
near (3 bases from 5'-end) the 5'-end of exon 2 and the 5'-end of exon
3. This was cut by ClaI and ligated, which resulted in a
truncation of most of exon 2 (denoted as p1
A(CC)34). The
p1
A(CC)34 was further digested by ClaI and
SacI and ligated to make p1
A(CSc)4. The p1
A(CC)34 was
linearized by SfuI or BamHI, whose in
vitro transcript was 1
A(CC)Sf or 1
A(CC)Bam. The p1
A(CSc)4
was linearized by BamHI, resulting in the 1
A(CSc)Bam RNA
transcript (Fig. 7A
). The p1
A234 was digested with HincII
and SacI, and ligated, generating the p1
A2(HSc)4. The
p1
A234 was digested with HincII and Sfu1,
which produced the p1
A2(HSf)34. These plasmids were linearized by
BamHI, producing 1
A(HSc)Bam and 1
A(HSf)Bam RNA
transcripts, respectively (Fig. 7B
). The A2B3 DNA was obtained by PCR
from rat brain genomic DNA with iA-up and e3-down primers and cloned
into the pGEM-T vector (denoted as pA2B3). EcoRI site in the
middle of intron B was cut, and this linearized DNA was treated with
the ExoIII nuclease and S1 nuclease followed by ligation, generating
the pA2
B3. The HincII site in exon 2 and SacI
site in exon 3 were cut, and this DNA fragment was subcloned into the
pGEM4Z vector, resulting in the p2
B3. Using iB-up and e4-down
primers, the pB3C4 was cloned. Intron B and a part of exon 3 were
removed by digestion with ApaI and SfuI (p3C4).
This clone was further digested by PstI and NcoI
to remove the inner part of intron C, generating the p3
C4 (Fig. 3
).
Site-directed mutation of the 5'- and 3'-splice site of intron A was
performed by PCR with mutated primers. The sequence of the 5'-splice
site of intron A (GUAAAA) was substituted to
GUAAGU (1
A(5'm)H) and the sequence of the 3'-splice site
(UGUGUCUUGAUGUCCCUUAG)
was replaced by
UCUCUCUUGAUCUCCCUCAG
(1
A(3'm)H). Mutation of both sites was denoted as 1
A(5'3'm)H. The
1
A(3'mBPS)H RNA has a sequence of
UACUGAUCCCUCUCUCUCUUUUUCUCCCUCAG.
Underlines show the changed bases from the 1
A(3'm)H, and
bold characters indicate the BPS (Fig. 4
). Site-directed
mutation of the ESE3 and ESE4 was performed by PCR with mutated primers
as shown in diagram of Fig. 11
. All the final products were
sequenced by Sanger dideoxy method (Sequenase 2.0, Amersham Pharmacia Biotech).
In Vitro Splicing Reactions
Pre-mRNA substrates were synthesized in 25 µl in
vitro transcription reactions containing 200 ng of template DNA,
10 U of T7 RNA polymerase (Roche Molecular Biochemicals,
Nutley, NJ), 0.5 mM diguanosinetriphosphate (Roche Molecular Biochemicals), 0.5 mM ATP and CTP, 0.05
mM GTP, 15 µM UTP, and 2.5 µl of
[32P]UTP (Amersham Pharmacia Biotech). The
RNAs were purified by electrophoresis on a 6% polyacrylamide gel
containing 8 M urea. The purified RNA substrates (usually
about 20,000 cpm) were applied to the splicing reaction in a total
volume of 25 µl containing 5 mM HEPES, pH 7.9, 20
mM creatine phosphate, 0.4 mM ATP, 0.6%
polyvinyl alcohol, 3 mM MgCl2, 100 µg HeLa
NE, and 20 U RNasin according to the manufacturers protocols
(Promega Corp.). In the case of replacement experiments in
Figs. 811


, the half-volume (50 µg) of HeLa NE was replaced by NE
storage buffer, 10 µg or 20 µg of GT1 NE. The splicing reaction was
performed at 30 C for 3 h and stopped by the addition of the 2x
stop mix containing 0.5% SDS, 2 mM EDTA, 3 µg/ml tRNA,
0.03 M sodium acetate, and 0.03 M Tris-HCl, pH
7.4. After the phenol/chloroform extraction and subsequent ethanol
precipitation, the RNAs were analyzed on 6% polyacrylamide gels
containing 8 M urea (15).
GT1 NE Preparation
GT11 cells (kindly provided by R.I. Weiner, University of
California at San Francisco, San Francisco, CA) were maintained in DMEM
with 10% FCS under a humidifying atmosphere containing 5%
CO2 at 37 C. About 3 x 108 GT11 cells
were harvested from the cell culture media. The NE was prepared as
described by Dignam et al. (38) with a slight modification.
Several protease inhibitors (1 µg/ml aprotinin, 0.5 µg/ml
leupeptin, 0.7 µg/ml pepstatin A) were included in the normal buffer
containing 0.3 M HEPES (pH 7.9), 25% (vol/vol) glycerol,
0.42 M NaCl, 1.5 mM MgCl2, 0.2
mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride
(PMSF), and 0.5 mM dithiothreitol (DTT). Instead of buffer
D, a nuclear storage buffer containing 40 mM Tris-HCl (pH
7.4), 100 mM KCl, 0.2 mM EDTA, 0.5
mM DTT, 0.5 mM PMSF, 25% (vol/vol) glycerol
was used. The protein concentration was usually 45 mg per
ml.
 |
FOOTNOTES
|
---|
Address requests for reprints to: Kyungjin Kim, Ph.D., Department of Molecular Biology, College of Natural Sciences, Seoul National University, Seoul 151742, Korea.
The present study was supported in part by the Korea Science and
Engineering Foundation (KOSEF) through the Research Center for Cell
Differentiation and by Ministry of Science and Technology through Korea
Brain Science Program.
Received for publication November 24, 1998.
Revision received April 6, 1999.
Accepted for publication August 4, 1999.
 |
REFERENCES
|
---|
-
Adelman JP, Mason AJ, Hayflick JS, Seeburg PH 1986 Isolation of the gene and hypothalamic cDNA for the common precursor of
gonadotropin-releasing hormone and prolactin-inhibiting factor in human
and rat. Proc Natl Acad Sci USA 83:179183[Abstract]
-
Bond CT, Hayflick JS, Seeburg PH, Adelman JP 1989 The rat
gonadotropin-releasing hormone: SH locus: structure and hypothalamic
expression. Mol Endocrinol 3:12571262[Abstract]
-
Oikawa M, Dargan C, Ny T, Hsueh AJW 1990 Expression of
gonadotropin-releasing hormone and prothymosin-
messenger
ribonucleic acid in the ovary. Endocrinology 127:23502356[Abstract]
-
Azad N, Emanuele NV, Halloran MM, Tentler J, Kelley M 1991 Presence of luteinizing hormone-releasing (LHRH) mRNA in rat spleen
lymphocytes. Endocrinology 128:16791681[Abstract]
-
Pagesy P, Li JY, Berthet M, Peilon F 1992 Evidence of
gonadotropin-releasing hormone mRNA in the rat anterior pituitary. Mol
Endocrinol 6:523528[Abstract]
-
Choi WS, Kim MO, Lee BJ, Kim JH, Sun W, Seong JY, Kim K 1994 Presence of gonadotropin-releasing hormone mRNA in the rat olfactory
piriform cortex. Brain Res 648:148151[CrossRef][Medline]
-
Radovick S, Wondisford FE, Nakayama Y, Yamada M, Cutler Jr
GB, Weintraub BD 1990 Isolation and characterization of the human
gonadotropin-releasing hormone gene in the hypothalamus and placenta.
Mol Endocrinol 4:476480[Abstract]
-
Dong K-W, Duval P, Zeng Z, Gordon K, Williams RF, Hodgen GD,
Jones G, Kerdelhue B, Roberts JL 1996 Multiple transcription start
sites for the GnRH gene in rhesus and cynomolgus monkeys: a non-human
primate model for studying GnRH gene regulation. Mol Cell Endocrinol 117:121130[CrossRef][Medline]
-
Goubau S, Bond CT, Adelman JP, Misra V, Hynes MF, Schultz GA,
Murphy BD 1992 Partial characterization of the gonadotropin-releasing
hormone (GnRH) gene transcript in the rat ovary. Endocrinology 130:30983100[Abstract]
-
Zhen S, Dunn IC, Wray S, Liu Y, Chappell PE, Levine JE,
Radovick S 1997 An alternative gonadotropin-releasing hormone (GnRH)
RNA splicing product found in cultured GnRH neurons and mouse
hypothalamus. J Biol Chem 272:1262012625[Abstract/Free Full Text]
-
Jakubowski M, Roberts JL 1994 Processing of
gonadotropin-releasing hormone gene transcripts in the rat brain.
J Biol Chem 269:40784083[Abstract/Free Full Text]
-
Yeo TT, Gore AC, Jakubowski M, Dong KW, Blum M, Roberts JL 1996 Characterization of gonadotropin-releasing hormone gene
transcripts in a mouse hypothalamic neuronal GT1 cell line. Mol Brain
Res 42:255262[Medline]
-
Gore AC, Roberts JL 1997 Regulation of gonadotropin-releasing
hormone gene expression in vivo and in vitro.
Front Neuroendocrinol 18:209245[CrossRef][Medline]
-
Silverman A-J, Livne I, Witkin JW 1994 The
gonadotropin-releasing hormone (GnRH) neuronal system:
immunocytochemistry and in situ hybridization. In: Knobil E,
Neill JD (eds) The Physiology of Reproduction. Raven Press, New York,
vol 1:16831709
-
Tian M, Maniatis T 1994 A splicing enhancer exhibits both
constitutive and regulated activities. Genes Dev 8:17031712[Abstract]
-
Sakamoto H, Ohno M, Yasuda K, Mizumoto K, Shimura Y 1987 In vitro splicing of a chicken
-crystallin pre-mRNA in a
mammalian nuclear extract. J Biochem 102:12891301[Abstract]
-
Min H, Turck CW, Nikolic JM, Black DL 1997 A new regulatory
protein, KSRP, mediates exon inclusion through an intronic splicing
enhancer. Genes Dev 11:10231036[Abstract]
-
Manley JL, Tacke R 1996 SR proteins and splicing control.
Genes Dev 10:15691579[CrossRef][Medline]
-
Shapiro MB, Senapathy P 1987 RNA splice junctions of different
classes of eukaryotes: sequence statistics and functional implications
in gene expression. Nucleic Acids Res 15:71557174[Abstract]
-
Gozani O, Feld R, Reed R 1996 Evidence that
sequence-independent binding of highly conserved U2 snRNP proteins
upstream of the branch site is required for assembly of spliceosomal
complex A. Genes Dev 10:233243[Abstract]
-
Berglund JA, Chua K, Abovich N, Reed R, Rosbash M 1997 The
splicing factor BBP interacts specifically with the pre-mRNA
branchpoint sequence UACUAAC. Cell 89:781787[Medline]
-
Dirksen WP, Hampson RK, Sun Q, Rottman FM 1994 A purine-rich
exon sequence enhances alternative splicing of bovine growth hormone
pre-mRNA. J Biol Chem 269:64316436[Abstract/Free Full Text]
-
Dirksen WP, Sun Q, Rottman FM 1995 Multiple splicing signals
control alternative intron retention of bovine growth hormone pre-mRNA.
J Biol Chem 270:53465352[Abstract/Free Full Text]
-
Tanaka K, Watakabe A, Shimura Y 1994 Polypurine sequences
within a downstream exon function as a splicing enhancer. Mol Cell Biol 14:13471354[Abstract]
-
Mellon PL, Windle JJ, Goldsmith PC, Padula CA, Roberts JL,
Weiner RI 1990 Immortalization of hypothalamic GnRH neurons by
genetically targeted tumorigenesis. Neuron 5:110[Medline]
-
Cohen RB, Boal TR, Safer B 1990 Increased eIF-2
expression
in mitogen-activated primary T lymphocytes. EMBO J 9:38313837[Abstract]
-
Kiledjan M, Kadesh T 1991 Post-transcriptional regulation of
the human liver/bone/kidney alkaline phosphatase gene. J Biol Chem 266:42074213[Abstract/Free Full Text]
-
Song MKH, Dozin B, Grieco D, Rall JE, Nikodem VM 1988 Transcriptional activation and stabilization of malic enzyme mRNA
precursor by thyroid hormone. J Biol Chem 263:1797017974[Abstract/Free Full Text]
-
Meskini RE, Boudouresque F, Ouafik L 1997 Estrogen regulation
of peptidylglycine
-amidating monooxygenase messenger ribonucleic
acid levels by a nuclear posttranscriptional event. Endocrinology 138:52565265[Abstract/Free Full Text]
-
Chiara MD, Gozani O, Bennett M, Champion-Arnaud P, Leon P,
Reed R 1996 Identification of proteins that interact with exon
sequence, splice sites, and the branchpoint sequence during each stage
of spliceosome assembly. Mol Cell Biol 16:33173326[Abstract]
-
Lowery DE, Van Ness BG 1988 Comparison of in vitro
and in vivo splice site selection in
-immunoglobulin
precursor mRNA. Mol Cell Biol 8:26102619[Medline]
-
Watakabe A, Tanaka K, Shimura Y 1993 The role of exon
sequences in splice site selection. Genes Dev 7:407418[Abstract]
-
Okano HJ, Darnell RB 1997 A hierarchy of Hu RNA binding
proteins in developing and adult neurons. J Neurosci 17:30273037
-
Chomczynski P, Sacchi N 1987 Single-step method of RNA
isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal Biochem 162:156159[CrossRef][Medline]
-
Seong JY, Lee YK, Lee CC, Kim K 1993 NMDA receptor antagonist
decreases the progesterone-induced increase in GnRH gene expression in
the rat hypothalamus. Neuroendocrinology 58:234239[Medline]
-
Kim K, Jarry H, Knoke I, Seong JY, Leonhardt S, Wuttke W 1993 Competitive PCR for quantitation of GnRH mRNA level in a single
micropunch of the rat preoptic area. Mol Cell Endocrinol 97:153158[CrossRef][Medline]
-
Seong JY, Jarry H, Kühnemuth S, Leonhardt S, Wuttke W,
Kim K 1995 Effect of GABAergic compounds on gonadotropin-releasing
hormone receptor gene expression in the rat. Endocrinology 136:25872593[Abstract]
-
Dignam JD, Lebovitz RM, Roeder RG 1983 Accurate transcription
initiation by RNA polymerase II in a soluble extract from isolated
mammalian nuclei. Nucleic Acids Res 11:14751489[Abstract]